EVALUATION OF MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION AS A TOOL FOR DIAGNOSIS AND CARRIER DETECTION IN...

Area of Science:

• Genetics
• Molecular Biology
• Neuromuscular Disorders

Background:

• Dystrophinopathies, including Duchenne and Becker muscular dystrophy, require accurate molecular diagnosis and carrier detection.
• Traditional methods like multiplex PCR have limitations in detecting all types of DMD gene mutations.

Purpose of the Study:

• To evaluate the efficacy of multiplex ligation-dependent probe amplification (MLPA) for diagnosing dystrophinopathies.
• To assess MLPA's utility in carrier detection for families affected by these genetic disorders.

Main Methods:

• Fifty-three Indian families with suspected dystrophinopathy were analyzed using MLPA and multiplex PCR.
• Sanger sequencing was employed for comprehensive gene analysis in one patient.
• Carrier status was determined for mothers whenever feasible.

Main Results:

• A combined mutation detection rate of 62% was achieved using MLPA and multiplex PCR.
• Deletions were identified in 51% of cases, duplications in 9%, and a nonsense mutation in one case.
• MLPA refined multiplex PCR results, detecting deletions and duplications missed by the latter, and identified carriers in 56% of mothers.

Conclusions:

• MLPA is a valuable tool for the diagnosis and carrier detection of dystrophinopathies.
• MLPA offers superior detection of deletions and duplications compared to traditional multiplex PCR.
• Accurate molecular diagnosis is crucial for genetic counseling and management of dystrophinopathies.